Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

InSaKa Trial: Insulin Dextrose Infusion Versus Nebulized Salbutamol Versus Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia: a Randomized Clinical Trial

NCT04012138 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT04012138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04012138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
InSaKa Trial: Insulin Dextrose Infusion Versus Nebulized Salbutamol Versus Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia: a Randomized Clinical Trial
Lead sponsor
Nantes University Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 20, 2019
Completion date
December 20, 2025
Enrollment
419 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia